Arterial Blood Pressure at Liver Transplant Evaluation Predicts Renal Histology in Candidates With Renal Dysfunction.


Journal

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
ISSN: 1527-6473
Titre abrégé: Liver Transpl
Pays: United States
ID NLM: 100909185

Informations de publication

Date de publication:
12 2019
Historique:
received: 13 07 2019
accepted: 16 09 2019
pubmed: 10 10 2019
medline: 18 9 2020
entrez: 10 10 2019
Statut: ppublish

Résumé

Renal dysfunction is common in liver transplantation (LT) candidates, but differentiating between reversible and irreversible renal injury can be difficult. Kidney biopsy might be helpful in differentiating reversible from irreversible renal injury, but it is associated with significant complications. We aimed to identify pre-LT predictors of potentially reversible renal injury using histological information obtained on pre-LT renal biopsy. Data on 128 LT candidates who underwent pre-LT kidney biopsy were retrospectively collected and correlated with renal histological findings. Indications for kidney biopsy were iothalamate glomerular filtration rate (iGFR) ≤40 mL/minute, proteinuria >500 mg/day, and/or hematuria. According to the biopsy diagnosis, patients were grouped into the following categories: normal (n = 13); acute tubular necrosis (ATN; n = 25); membranoproliferative glomerulonephritis (n = 19); minimal histological changes (n = 24); and advanced interstitial fibrosis (IF) and glomerulosclerosis (GS) (n = 47). Compared with patients having advanced IF/GS, patients with normal biopsies and those with ATN had lower systolic blood pressure (SBP) and diastolic blood pressure (DBP) and higher international normalized ratio and total bilirubin levels (<0.05 for all). Both SBP and DBP directly correlated with the degree of IF and GS (R = 0.3, P ≤ 0.02 for all). SBP ≤90 mm Hg was 100% sensitive and 98% specific in correlating with normal biopsies or ATN, whereas SBP ≥140 mm Hg was 22% sensitive and 90% specific in correlating with advanced IF/GS. Model for End-Stage Liver Disease score, serum creatinine, iGFR, urinary sodium excretion, and renal size did not correlate with biopsy diagnosis or degree of IF or GS. In conclusion, SBP at the time of LT evaluation correlates with renal histology, and it should be included along with other clinical and laboratory markers in the decision-making process to list patients with renal dysfunction for LT alone versus simultaneous liver-kidney transplantation.

Identifiants

pubmed: 31597218
doi: 10.1002/lt.25651
doi:

Substances chimiques

Creatinine AYI8EX34EU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1756-1767

Informations de copyright

Copyright © 2019 by the American Association for the Study of Liver Diseases.

Références

Nair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002;35:1179-1185.
Gonwa TA, McBride MA, Anderson K, Mai ML, Wadei H, Ahsan N. Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us? Am J Transplant 2006;6:2651-2659.
Francoz C, Glotz D, Moreau R, Durand F. The evaluation of renal function and disease in patients with cirrhosis. J Hepatol 2010;52:605-613.
Wong F, O'Leary JG, Reddy KR, Garcia-Tsao G, Fallon MB, Biggins SW, et al. Acute kidney injury in cirrhosis: baseline serum creatinine predicts patient outcomes. Am J Gastroenterol 2017;112:1103-1110.
Francis JM, Palmer MR, Donohoe K, Curry M, Johnson SR, Karp SJ, et al. Evaluation of native kidney recovery after simultaneous liver-kidney transplantation. Transplantation 2012;93:530-535.
Levitsky J, Baker T, Ahya SN, Levin ML, Friedewald J, Gallon L, et al. Outcomes and native renal recovery following simultaneous liver-kidney transplantation. Am J Transplant 2012;12:2949-2957.
Lum EL, Cárdenas A, Martin P, Bunnapradist S. Current status of simultaneous liver-kidney transplantation in the United States. Liver Transpl 2019;25:797-806.
VanWagner LB, Lapin B, Skaro AI, Lloyd-Jones DM, Rinella ME. Impact of renal impairment on cardiovascular disease mortality after liver transplantation for nonalcoholic steatohepatitis cirrhosis. Liver Int 2015;35:2575-2583.
Wadei HM, Geiger XJ, Cortese C, Mai ML, Kramer DJ, Rosser BG, et al. Kidney allocation to liver transplant candidates with renal failure of undetermined etiology: role of percutaneous renal biopsy. Am J Transplant 2008;8:2618-2626.
Trawalé JM, Paradis V, Rautou PE, Francoz C, Escolano S, Sallée M, et al. The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study. Liver Int 2010;30:725-732.
Nadim MK, Davis CL, Sung R, Kellum JA, Genyk YS. Simultaneous liver-kidney transplantation: a survey of US transplant centers. Am J Transplant 2012;12:3119-3127.
Wadei HM, Heckman MG, Rawal B, Taner CB, Mai ML, Cortese C, et al. Renal outcomes of liver transplant recipients who had pretransplant kidney biopsy. Transplantation 2014;98:1323-1330.
Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodés J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988;8:1151-1157.
Ruiz-del-Arbol L, Monescillo A, Arocena C, Valer P, Ginès P, Moreira V, et al. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology 2005;42:439-447.
Bernardi M, Moreau R, Angeli P, Schnabl B, Arroyo V. Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis. J Hepatol 2015;63:1272-1284.
Krag A, Bendtsen F, Henriksen JH, Møller S. Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites. Gut 2010;59:105-110.
Henriksen JH, Moller S. Liver cirrhosis and arterial hypertension. World J Gastroenterol 2006;12:678-685.
Loyke HF. The relationship of cirrhosis of the liver to hypertension: a study of 504 cases of cirrhosis of the liver. Am J Med Sci 1955;230:627-632.
Loyke HF, Cutarelli R. An evaluation of hypertension and liver disease in an alcoholic service. Am J Med Sci 1960;240:346-348.
Eason JD, Gonwa TA, Davis CL, Sung RS, Gerber D, Bloom RD. Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK). Am J Transplant 2008;8:2243-2251.
Al Turk AA, Estiverne C, Agrawal PR, Michaud JM. Trends and outcomes of the use of percutaneous native kidney biopsy in the United States: 5-year data analysis of the Nationwide Inpatient Sample. Clin Kidney J 2018;11:330-336.
Boyle G. Simultaneous Liver Kidney (SLK) Allocation Policy. Rockville, MD: Department of Health and Human Services; 2016.
Hmoud B, Kuo YF, Wiesner RH, Singal AK. Outcomes of liver transplantation alone after listing for simultaneous kidney: comparison to simultaneous liver kidney transplantation. Transplantation 2015;99:823-828.
Sharma P, Goodrich NP, Zhang M, Guidinger MK, Schaubel DE, Merion RM. Short-term pretransplant renal replacement therapy and renal nonrecovery after liver transplantation alone. Clin J Am Soc Nephrol 2013;8:1135-1142.
Wadei HM, Lee DD, Croome KP, Mai L, Leonard D, Mai ML, et al. Early allograft dysfunction is associated with higher risk of renal nonrecovery after liver transplantation. Transplant Direct 2018;4:e352.
Myers MG, Asmar R, Staessen JA. Office blood pressure measurement in the 21st century. J Clin Hypertens (Greenwich) 2018;20:1104-1107.
Kim WR, Lake JR, Smith JM, Schladt DP, Skeans MA, Noreen SM, et al. OPTN/SRTR 2017 annual data report: liver. Am J Transplant 2019;19(suppl 2):184-283.

Auteurs

Hani M Wadei (HM)

Department of Transplant, Mayo Clinic, Jacksonville, FL.

Peter Abader (P)

Department of Transplant, Mayo Clinic, Jacksonville, FL.

Ali A Alsaad (AA)

Department of Internal Medicine, Mayo Clinic, Jacksonville, FL.

Kristopher Croome (K)

Department of Transplant, Mayo Clinic, Jacksonville, FL.

Cherise Cortese (C)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL.

Xochiquetzal J Geiger (XJ)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL.

Samir Khouzam (S)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL.

Martin L Mai (ML)

Department of Transplant, Mayo Clinic, Jacksonville, FL.

C Burcin Taner (CB)

Department of Transplant, Mayo Clinic, Jacksonville, FL.

Andrew P Keaveny (AP)

Department of Transplant, Mayo Clinic, Jacksonville, FL.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH